Pharmacotherapy for Neuropathic Pain

@article{Jackson2006PharmacotherapyFN,
  title={Pharmacotherapy for Neuropathic Pain},
  author={Kenneth C. Jackson},
  journal={Pain Practice},
  year={2006},
  volume={6}
}
  • K. Jackson
  • Published 1 March 2006
  • Medicine
  • Pain Practice
Abstract:  Refractory neuropathic pain can be devastating to a patient's quality of life. Ideally, the primary goal of therapy would be to prevent the pain, yet even the most appropriate treatment strategy may be only able to reduce the pain to a more tolerable level. Pharmacotherapy is currently the mainstay of treatment in patients with neuropathic pain, although at present the drugs are used on a mainly “off‐label” basis. A wide variety of agents are used, especially antidepressants (ie… 
Neuropathic pain: strategies in drug discovery and treatment
TLDR
A review of the various strategies and approaches to novel drug discovery and pharmacotherapy of neuropathic pain syndromes discusses the various methods of modulation of N-type Ca2+ channels.
Reducing and eliminating neuropathic pain.
TLDR
The rapidly evolving symptom- and mechanism-based approaches to the treatment of neuropathic pain holds promise for improving the quality of life of patients with neuropathy, and the great need remains for development of new and more effective approaches.
Pharmacological Management of Neuropathic Pain: Current Trends and Possible Approaches
TLDR
The available pharmacological approaches are effective on one or other types of chronic pain, but the inadequate pain relief and limitations with each class of drugs raises the need to develop better therapeutic approaches and also understand the pathology better.
Assessment of neuropathic pain in primary care.
Multifunctional Opioid-Derived Hybrids in Neuropathic Pain: Preclinical Evidence, Ideas and Challenges
TLDR
Rational design of hybrid drugs, in which opioid ligands are combined with other pharmacophores that block the antiopioid action of pronociceptive systems, delivers the opportunity to ameliorate the NP-oriented opioid treatment via addressing neuropathological mechanisms shared both by NP and repeated exposition to opioids.
Evaluation of topical versus systemic medications in the treatment of neuropathic orofacial pain A prospective study
TLDR
Topical medication as a single treatment is more efficient in reduction of neuropathic orofacial pain within shorter period and no side effects than systemic medications.
Pharmacological and interventional treatments for neuropathic pain
TLDR
A rational approach for the treatment of specific neuropathic conditions is presented in the form of tables that consider first line, second line, and other therapies.
The role of pregabalin in neuropathic pain management in cancer patients
Despite the wide availability of analgesics for prescription in cancer pain, including both opioid and non-opioid medications, population studies have for many years demonstrated unadvisable pain
Artículos originales New Generation Antidepressants in Painful Diabetic Neuropathy
TLDR
A meta-analysis of the possible role of new-generation antidepressive agents in the treatment of pain in diabetic peripheral neuropathy covered the Cochrane, MEDLINE, EMBASE and LILACS databases between January 2000 and August 2007 and indicated that duloxetine, was effective for controllingPain in diabetic neuropathy.
New Generation Antidepressants in Painful Diabetic Neuropathy
TLDR
A meta-analysis of the possible role of new-generation antidepressive agents in the treatment of pain in diabetic peripheral neuropathy covered the Cochrane, MEDLINE, EMBASE and LILACS databases between January 2000 and August 2007 and indicated that duloxetine, was effective for controllingPain in diabetic neuropathy.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 77 REFERENCES
Pharmacologic management part 1: better-studied neuropathic pain diseases.
TLDR
Anticonvulsants, such as gabapentin, carbamazepine, and lamotrigine), and tricyclic antidepressants, including amitriptyline and desipramine, have demonstrated efficacy in relieving pain associated with postherpetic neuralgia, diabetic peripheral neuropathy, and trigeminal neuralgio, in several studies, but the lack of head-to-head comparison studies of these agents limits the conclusions that can be reached.
Neurophatic Pain Treatment: The Challenge
TLDR
Novel therapies are currently being developed for neuropathic pain that are based in experimental models and theoretical frameworks on the pathosphysiological events that initiate this type of pain.
Management of Peripheral Neuropathic Pain
  • B. Stacey
  • Medicine, Psychology
    American journal of physical medicine & rehabilitation
  • 2005
TLDR
An overview of the cellular mechanisms associated with neuropathic pain is presented, the results of randomized, controlled trials with the major classes of available drugs are summarized, and treatment options that provide a rational basis for pharmacotherapy are discussed.
Pharmacologic management part 2: lesser-studied neuropathic pain diseases.
TLDR
The results of published trials do support the use of anticonvulsants and/or tricyclic antidepressants as first-line pharmacotherapy in these three neuropathic pain syndromes.
Chronic Neuropathic Pain: Mechanisms, Diagnosis, and Treatment
TLDR
The rapidly evolving symptom- and mechanism-based approach to the treatment of neuropathic pain holds promise for improving the quality of life of patients with neuropathicPain.
Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations.
TLDR
Randomized controlled clinical trials of gabapentin, the 5% lidocaine patch, opioid analgesics, tramadol hydrochloride, and tricyclic antidepressants provide an evidence-based approach to the treatment of neuropathic pain.
Pharmacotherapy of complex regional pain syndrome.
  • R. Harden
  • Medicine, Psychology
    American journal of physical medicine & rehabilitation
  • 2005
TLDR
An overview of available data regarding drug and interventional treatment options for complex regional pain syndrome and of those relevant pharmacotherapies the authors can derive from the neuropathy literature is presented.
...
1
2
3
4
5
...